Chuang L M, Wu H P, Chang C C, Tsai W Y, Chang H M, Tai T Y, Lin B J
Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei.
Clin Endocrinol (Oxf). 1996 Nov;45(5):631-6. doi: 10.1046/j.1365-2265.1996.00857.x.
Thyroid autoimmunity is frequently associated with insulin-dependent diabetes mellitus (IDDM). The genetic factors which contribute to thyroid autoimmunity and IDDM have been described but vary between different races. We have therefore investigated the effect of class II HLA genes at both loci and the HLA haplotypes on the presence of autoimmunity in patients with IDDM in Taiwan.
Eighty-three patients with IDDM and 105 unrelated normal controls were recruited for the measurement of thyroid autoantibodies and for genotyping of HLA DRB1, DQA1 and DQB1 by polymerase chain reaction-based DNA typing techniques.
Among 83 patients with IDDM, 23 (27.7%) were positive for antithyroid autoantibodies. Compared to those without thyroid autoimmunity, there was a female preponderance for IDDM with thyroid autoimmunity (female: male, 3:20 vs 29:31). Among the DR specificities, DR6 was associated with a weak protective effect against thyroid autoimmunity in IDDM patients. Upon detailed analysis of class II HLA haplotypes, the DRB10301/ DQA10501/DQB10201 haplotype was found to be associated with an increased risk of IDDM regardless of thyroid autoimmunity, while DRB10405/DQA10301/ DQB10401 was significantly increased only in the IDDM patients with thyroid autoimmunity. IDDM individuals with the HLA DRB10405/DQA10301/DQB1*0302 haplotype were not at risk of thyroid autoimmunity.
Our data indicated that there was a generalized genetic factor within or associated with the DRB10301/DQA10501/DQB10201 haplotype, and a more restricted effect with the DRB10405/DQA10301/DQB10401 haplotype which led to thyroid autoimmunity in patients with insulin-dependent diabetes mellitus.
甲状腺自身免疫常与胰岛素依赖型糖尿病(IDDM)相关。已描述了导致甲状腺自身免疫和IDDM的遗传因素,但在不同种族之间存在差异。因此,我们研究了台湾IDDM患者中两个位点的II类HLA基因及HLA单倍型对自身免疫存在情况的影响。
招募了83例IDDM患者和105名无关的正常对照,用于检测甲状腺自身抗体,并通过基于聚合酶链反应的DNA分型技术对HLA DRB1、DQA1和DQB1进行基因分型。
在83例IDDM患者中,23例(27.7%)抗甲状腺自身抗体呈阳性。与无甲状腺自身免疫的患者相比,有甲状腺自身免疫的IDDM患者中女性占优势(女性:男性,3:20对比29:31)。在DR特异性中,DR6与对IDDM患者甲状腺自身免疫有较弱的保护作用相关。对II类HLA单倍型进行详细分析后发现,无论甲状腺自身免疫情况如何,DRB10301/DQA10501/DQB10201单倍型与IDDM风险增加相关,而DRB10405/DQA10301/DQB10401仅在有甲状腺自身免疫的IDDM患者中显著增加。具有HLA DRB10405/DQA10301/DQB1*0302单倍型的IDDM个体无甲状腺自身免疫风险。
我们的数据表明,DRB10301/DQA10501/DQB10201单倍型内部存在或与之相关的一个普遍遗传因素,以及DRB10405/DQA10301/DQB10401单倍型更具局限性的影响,导致胰岛素依赖型糖尿病患者出现甲状腺自身免疫。